|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 668.78 USD | +0.89% |
|
+2.03% | -13.52% |
| 11:55am | Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Market Cap | 67.44B 59.15B 54.61B 50.47B 95.65B 6,458B 97.57B 657B 255B 3,160B 253B 248B 10,970B | P/E 2026 * |
17.2x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 59.61B 52.28B 48.27B 44.6B 84.54B 5,707B 86.23B 580B 225B 2,793B 224B 219B 9,696B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.24x |
| Free-Float |
72.33% | Yield 2026 * |
0.59% | Yield 2027 * | 0.67% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.89% | ||
| 1 week | +2.03% | ||
| Current month | +7.06% | ||
| 1 month | +8.34% | ||
| 3 months | -13.06% | ||
| 6 months | -16.19% | ||
| Current year | -13.52% |
| 1 week | 637.72 |  | 677.92 |
| 1 month | 594.9 | | 677.92 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Sell | Director | -200 | 0.0002% | ||
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.89% | +2.03% | +20.81% | -5.09% | 67.44B | |
| +1.97% | -4.16% | +48.91% | +223.30% | 53.98B | |
| -4.15% | +36.30% | +36.30% | +36.30% | 41.77B | |
| +0.99% | +6.61% | -48.49% | -52.47% | 41.15B | |
| -1.42% | -9.09% | +47.70% | -30.23% | 29.58B | |
| +2.05% | -6.33% | +131.29% | -38.39% | 29.28B | |
| +0.23% | +1.02% | +71.78% | +90.74% | 23.43B | |
| +0.17% | +1.17% | +4.98% | +190.25% | 19.11B | |
| +0.91% | -0.67% | +67.98% | +133.30% | 16.82B | |
| +19.12% | +15.57% | +94.01% | +413.87% | 15.36B | |
| Average | +2.07% | +2.05% | +47.53% | +96.16% | 33.79B | |
| Weighted average by Cap. | +1.09% | +1.69% | +39.02% | +69.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.87B 13.92B 12.85B 11.88B 22.51B 1,520B 22.96B 155B 60.04B 744B 59.61B 58.3B 2,582B | 17.55B 15.39B 14.21B 13.13B 24.89B 1,680B 25.39B 171B 66.37B 822B 65.9B 64.46B 2,854B |
| Net income | 4.06B 3.56B 3.29B 3.04B 5.76B 389B 5.88B 39.54B 15.36B 190B 15.25B 14.92B 661B | 5.11B 4.48B 4.13B 3.82B 7.24B 489B 7.39B 49.7B 19.31B 239B 19.17B 18.75B 830B |
| Net Debt | -7.83B -6.87B -6.34B -5.86B -11.11B -750B -11.33B -76.26B -29.63B -367B -29.42B -28.77B -1,274B | -10.5B -9.21B -8.5B -7.86B -14.89B -1,006B -15.19B -102B -39.72B -492B -39.44B -38.57B -1,708B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$664.51 | +0.25% | 15,933 |
| 08/07/26 | US$662.88 | -1.97% | 746,834 |
| 07/07/26 | US$676.23 | +4.07% | 918,937 |
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
